CTOs on the Move

Vivant Medical

www.vivantmedical.com

 
Vivant Medical is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Jacobsen Real-Time X-Ray Mchy

Jacobsen Real-Time X-Ray Mchy is a Brampton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mazor Robotics

Mazor Robotics Renaissance Guidance System is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy. It is the only mechanical guidance system for spine surgery with FDA clearance and CE marking. Renaissance has been used in thousands of spine procedures worldwide ranging from minimally-invasive surgery to scoliosis and other complex spinal deformity cases.

Pathologists Bio Medical Lab

Pathologists Bio Medical Lab is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stormin Norman'S

Stormin Norman'S is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.